Fangfang Lai

2.2k total citations
68 papers, 1.8k citations indexed

About

Fangfang Lai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fangfang Lai has authored 68 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Fangfang Lai's work include Ion Transport and Channel Regulation (6 papers), Ubiquitin and proteasome pathways (5 papers) and Sphingolipid Metabolism and Signaling (5 papers). Fangfang Lai is often cited by papers focused on Ion Transport and Channel Regulation (6 papers), Ubiquitin and proteasome pathways (5 papers) and Sphingolipid Metabolism and Signaling (5 papers). Fangfang Lai collaborates with scholars based in China, United States and United Kingdom. Fangfang Lai's co-authors include Roger Williams, Mary Lou King, Xiaoguang Chen, Ming Ji, Nina Xue, Amar M. Singh, Yi Zhou, Xueting Luo, Zijian Xie and Jing Jin and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Development.

In The Last Decade

Fangfang Lai

67 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangfang Lai China 21 873 301 208 203 178 68 1.8k
Wei Jin China 25 998 1.1× 136 0.5× 118 0.6× 128 0.6× 171 1.0× 101 2.1k
Yi‐Chao Lee Taiwan 32 1.4k 1.6× 117 0.4× 217 1.0× 169 0.8× 215 1.2× 90 2.8k
Young Soo Ahn South Korea 27 1.3k 1.4× 212 0.7× 202 1.0× 327 1.6× 347 1.9× 60 2.4k
Yajing Liu China 24 1.5k 1.7× 306 1.0× 241 1.2× 132 0.7× 116 0.7× 117 2.4k
Vinay Choubey India 24 1.2k 1.3× 335 1.1× 88 0.4× 368 1.8× 272 1.5× 38 2.3k
Dinesh Upadhya India 23 830 1.0× 254 0.8× 131 0.6× 86 0.4× 83 0.5× 61 1.7k
Alexander R. Moise United States 32 2.2k 2.5× 58 0.2× 251 1.2× 156 0.8× 155 0.9× 52 2.9k
Jing Zhu China 25 1.7k 1.9× 94 0.3× 194 0.9× 133 0.7× 216 1.2× 86 2.3k
Davide Cervia Italy 35 1.3k 1.4× 81 0.3× 95 0.5× 266 1.3× 257 1.4× 88 2.7k

Countries citing papers authored by Fangfang Lai

Since Specialization
Citations

This map shows the geographic impact of Fangfang Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Lai more than expected).

Fields of papers citing papers by Fangfang Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangfang Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Lai. The network helps show where Fangfang Lai may publish in the future.

Co-authorship network of co-authors of Fangfang Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Fangfang Lai. A scholar is included among the top collaborators of Fangfang Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfang Lai. Fangfang Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xinyi, Junyi Liu, Jie Ma, et al.. (2025). Design and synthesis of novel sulfur-substituted triptolide with the ability to induce autophagy through inhibition of SRSF1 expression. European Journal of Medicinal Chemistry. 287. 117342–117342. 1 indexed citations
2.
Zhang, Chen, Yingda Zang, Jiaqi Chen, et al.. (2024). Previously undescribed tetrahydroanthraquinones from Prismatomeris tetrandra (roxb.) K. Schum with antitumor cell proliferation activities. Phytochemistry. 220. 113995–113995. 1 indexed citations
3.
Fu, Rong, Jun Tai, Xia Yuan, et al.. (2022). S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung. Acta Pharmaceutica Sinica B. 13(3). 1110–1127. 7 indexed citations
4.
Huang, Lei, Yunxuan Li, Yajun Yang, et al.. (2022). Identification of N, C-capped di- and tripeptides as selective immunoproteasome inhibitors. European Journal of Medicinal Chemistry. 234. 114252–114252. 4 indexed citations
5.
Zang, Yingda, Lei Huang, Xinyi Chen, et al.. (2022). Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies. European Journal of Medicinal Chemistry. 244. 114832–114832. 6 indexed citations
6.
Wei, Yuan, Chaoqun Liu, Fangfang Lai, et al.. (2021). Associations between serum total bilirubin, obesity and type 2 diabetes. Diabetology & Metabolic Syndrome. 13(1). 143–143. 18 indexed citations
7.
Zang, Yingda, Fangfang Lai, Chuang‐Jun Li, et al.. (2020). Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies. European Journal of Medicinal Chemistry. 190. 112079–112079. 25 indexed citations
8.
Yang, Yajun, Ke Wang, Bo Wu, et al.. (2020). Design, synthesis and biological evaluation of triaryl compounds as novel 20S proteasome inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(21). 127508–127508. 4 indexed citations
9.
Jin, Jing, Ming Ji, Rong Fu, et al.. (2019). Sphingosine-1-Phosphate Receptor Subtype 1 (S1P1) Modulator IMMH001 Regulates Adjuvant- and Collagen-Induced Arthritis. Frontiers in Pharmacology. 10. 1085–1085. 13 indexed citations
10.
He, Yujun, Jin Wen, Qinghua Cui, et al.. (2018). Quantitative Evaluation of in Vivo Target Efficacy of Anti-tumor Agents via an Immunofluorescence and EdU Labeling Strategy. Frontiers in Pharmacology. 9. 812–812. 7 indexed citations
11.
Ji, Ming, Nina Xue, Fangfang Lai, et al.. (2018). The Development of a Biotinylated NAD+-Applied Human Poly(ADP-Ribose) Polymerase 3 (PARP3) Enzymatic Assay. SLAS DISCOVERY. 23(6). 545–553. 6 indexed citations
12.
Yan, Lei, Fangfang Lai, Xiaoguang Chen, et al.. (2017). Design, synthesis and biological evaluation of novel indolin-2-ones as potent anticancer compounds. Bioorganic & Medicinal Chemistry Letters. 27(15). 3326–3331. 16 indexed citations
13.
Zhang, Sen, Dongjie Wang, Nina Xue, et al.. (2017). Nicousamide protects kidney podocyte by inhibiting the TGFβ receptor II phosphorylation and AGE-RAGE signaling.. PubMed Central. 9(1). 115–125. 12 indexed citations
14.
Lai, Fangfang, Qian Liu, Xiaoyu Liu, et al.. (2016). LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition. OncoTargets and Therapy. Volume 9. 3829–3840. 13 indexed citations
15.
Lai, Fangfang, Zhengwei Shen, Jialing Chen, et al.. (2016). A Morphological identification cell cytotoxicity assay using cytoplasm-localized fluorescent probe (CLFP) to distinguish living and dead cells. Biochemical and Biophysical Research Communications. 482(2). 257–263. 16 indexed citations
16.
Yan, Lei, Fangfang Lai, Xiaoguang Chen, & Zhiyan Xiao. (2015). Discovery of novel indirubin-3′-monoxime derivatives as potent inhibitors against CDK2 and CDK9. Bioorganic & Medicinal Chemistry Letters. 25(11). 2447–2451. 29 indexed citations
17.
Lai, Fangfang, et al.. (2014). [A novel HIF-1 inhibitor--manassantin A derivative LXY6099 inhibits tumor growth].. PubMed. 49(5). 622–6. 1 indexed citations
18.
Xu, Yanni, Qi Liu, Xu Yang, et al.. (2014). Rutaecarpine suppresses atherosclerosis in ApoE−/− mice through upregulating ABCA1 and SR-BI within RCT. Journal of Lipid Research. 55(8). 1634–1647. 55 indexed citations
19.
Lai, Fangfang, Qiqi Ye, Qiming Duan, et al.. (2013). Identification of a Mutant α1 Na/K-ATPase That Pumps but Is Defective in Signal Transduction. Journal of Biological Chemistry. 288(19). 13295–13304. 54 indexed citations
20.
Lai, Fangfang, et al.. (2010). Nanos1 functions as a translational repressor in the Xenopus germline. Mechanisms of Development. 128(1-2). 153–163. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei Jin Breakdown of academic impact, for papers by Yi‐Chao Lee Breakdown of academic impact, for papers by Young Soo Ahn Breakdown of academic impact, for papers by Yajing Liu Breakdown of academic impact, for papers by Vinay Choubey Breakdown of academic impact, for papers by Dinesh Upadhya Breakdown of academic impact, for papers by Alexander R. Moise Breakdown of academic impact, for papers by Jing Zhu Breakdown of academic impact, for papers by Davide Cervia
Rankless by CCL
2026